Novartis find sparks new GABA drug search.
Eccleston
A
A
D001709:Biotechnology; D015195:Drug Design; D004345:Drug Industry; D004832:Epilepsy, Absence / Q000188:drug therapy; D018755:GABA Agonists / Q000627:therapeutic use; D018756:GABA Antagonists / Q000627:therapeutic use; D006801:Humans; D007859:Learning Disabilities / Q000188:drug therapy; D008569:Memory Disorders / Q000188:drug therapy; D009515:New Jersey; D011963:Receptors, GABA-A / Q000502:physiology; D018080:Receptors, GABA-B / Q000502:physiology*; D006113:United Kingdom
D018755:GABA Agonists; D018756:GABA Antagonists; D011963:Receptors, GABA-A; D018080:Receptors, GABA-B